{"id":"sodium-enoxaparine","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Bleeding"},{"rate":"0.1-1","effect":"Thrombocytopenia"},{"rate":"5-10","effect":"Injection site hematoma"},{"rate":"1-3","effect":"Elevated transaminases"},{"rate":null,"effect":"Osteoporosis (with long-term use)"}]},"_chembl":{"chemblId":"CHEMBL1201685","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Enoxaparin is derived from unfractionated heparin and works by potentiating antithrombin III, a natural anticoagulant, to inactivate clotting factors Xa and IIa. This prevents thrombin generation and fibrin clot formation. It is administered subcutaneously and has more predictable pharmacokinetics than unfractionated heparin, making it suitable for both treatment and prophylaxis of thromboembolism.","oneSentence":"Sodium enoxaparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against factors Xa and IIa.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:28.224Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of venous thromboembolism in surgical patients"},{"name":"Treatment of acute deep vein thrombosis"},{"name":"Treatment of acute pulmonary embolism"},{"name":"Prophylaxis in medically immobilized patients"},{"name":"Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction)"}]},"trialDetails":[{"nctId":"NCT06825416","phase":"PHASE3","title":"A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2025-03-16","conditions":"Prevention of Arterial and Venous Thrombosis","enrollment":1166},{"nctId":"NCT07124819","phase":"PHASE3","title":"Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin","status":"COMPLETED","sponsor":"Avexima Diol LLC","startDate":"2024-07-22","conditions":"Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE)","enrollment":215},{"nctId":"NCT07270263","phase":"NA","title":"Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2024-11-22","conditions":"Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma","enrollment":100},{"nctId":"NCT01588171","phase":"NA","title":"Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-05","conditions":"Venous Thromboembolic Diseases","enrollment":7020},{"nctId":"NCT07116239","phase":"NA","title":"Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-09","conditions":"Nephrotic Syndrome, Hypoalbuminemia","enrollment":60},{"nctId":"NCT06220123","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2024-02-16","conditions":"Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","enrollment":225},{"nctId":"NCT06114641","phase":"PHASE4","title":"Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2023-06-01","conditions":"Safety Issues, Effect of Drug","enrollment":220},{"nctId":"NCT05484557","phase":"NA","title":"Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury","status":"RECRUITING","sponsor":"Loewenstein Hospital","startDate":"2023-09-06","conditions":"Spinal Cord Injuries, Spinal Diseases","enrollment":60},{"nctId":"NCT06963320","phase":"PHASE2","title":"Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2025-01-20","conditions":"Circulatory Disease","enrollment":320},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT05752461","phase":"PHASE2","title":"SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2023-04-12","conditions":"Prevention of Venous Thromboembolism After Knee Arthroplasty","enrollment":353},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT05129800","phase":"","title":"Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2011-01-01","conditions":"Androgenetic Alopecia, Hair Loss, Alopecia","enrollment":72},{"nctId":"NCT06662240","phase":"NA","title":"Effect of Vibration Anesthesia on Pain, Ecchymosis and Comfort Level in Subcutaneous Heparin Injection","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2024-03-15","conditions":"Pain, Ecchymosis, Comfort","enrollment":142},{"nctId":"NCT04164693","phase":"NA","title":"Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2019-01-01","conditions":"Thrombosis","enrollment":287},{"nctId":"NCT06222216","phase":"NA","title":"The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults","status":"RECRUITING","sponsor":"TC Erciyes University","startDate":"2024-03-01","conditions":"Pain, Ecchymosis, A Randomized Controlled Trial","enrollment":60},{"nctId":"NCT05081375","phase":"PHASE4","title":"Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures","status":"TERMINATED","sponsor":"Valleywise Health","startDate":"2019-12-16","conditions":"Venous Thrombosis Deep (Limbs), Surgical Blood Loss","enrollment":6},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT02342444","phase":"PHASE4","title":"Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2014-02","conditions":"Trauma, Surgery, Deep Vein Thrombosis (DVT)","enrollment":606},{"nctId":"NCT06293287","phase":"PHASE2","title":"Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy","status":"UNKNOWN","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2024-01-31","conditions":"Radial Artery Occlusion","enrollment":156},{"nctId":"NCT06049758","phase":"NA","title":"D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy","status":"NOT_YET_RECRUITING","sponsor":"General Committee of Teaching Hospitals and Institutes, Egypt","startDate":"2024-01-02","conditions":"Blood Loss, Intensive Care, Anastomotic Leakage","enrollment":80},{"nctId":"NCT04406389","phase":"PHASE4","title":"Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-10-13","conditions":"COVID-19","enrollment":14},{"nctId":"NCT03083704","phase":"PHASE1","title":"A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa","status":"COMPLETED","sponsor":"Portola Pharmaceuticals","startDate":"2017-02-26","conditions":"Bleeding","enrollment":153},{"nctId":"NCT05293132","phase":"PHASE2, PHASE3","title":"Effect of Montelukast Versus Co Enzyme in Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-02-01","conditions":"Sepsis","enrollment":90},{"nctId":"NCT02923115","phase":"PHASE1, PHASE2","title":"Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2016-06-23","conditions":"Pulmonary Embolism, Thrombotic Disease","enrollment":134},{"nctId":"NCT00680628","phase":"PHASE3","title":"Clot Dissolving Treatment for Blood Clots in the Lungs","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-05","conditions":"Pulmonary Embolism","enrollment":83},{"nctId":"NCT05334654","phase":"NA","title":"Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2022-04-20","conditions":"Acute Respiratory Failure, SARS CoV 2 Infection, Anticoagulants","enrollment":58},{"nctId":"NCT04492254","phase":"PHASE3","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"TERMINATED","sponsor":"Thrombosis Research Institute","startDate":"2020-10-27","conditions":"COVID-19","enrollment":219},{"nctId":"NCT05265676","phase":"PHASE1","title":"Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2021-02-26","conditions":"Healthy","enrollment":24},{"nctId":"NCT05185804","phase":"PHASE3","title":"Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19","status":"COMPLETED","sponsor":"PharmaDiall Ltd.","startDate":"2021-02-08","conditions":"COVID-19, Venous Thromboembolism","enrollment":399},{"nctId":"NCT04558125","phase":"PHASE4","title":"Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-09-08","conditions":"Pulmonary Embolism, COVID","enrollment":2},{"nctId":"NCT02486666","phase":"PHASE3","title":"Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2016-03","conditions":"Venous Thromboembolism","enrollment":20},{"nctId":"NCT04990830","phase":"PHASE2, PHASE3","title":"Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2021-02-03","conditions":"COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia","enrollment":80},{"nctId":"NCT02081950","phase":"PHASE1","title":"A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions","status":"COMPLETED","sponsor":"Chemi S.p.A.","startDate":"2014-03","conditions":"Clexane is Administered to Healthy Volunteers","enrollment":14},{"nctId":"NCT02232802","phase":"PHASE1","title":"Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.","status":"COMPLETED","sponsor":"Chemi S.p.A.","startDate":"2014-08-04","conditions":"Enoxaparin Sodium is Administered to Healthy Volunteers","enrollment":47},{"nctId":"NCT00633061","phase":"PHASE2","title":"Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2008-06","conditions":"Childhood Cancer, Central Venous Catheters, Deep Vein Thrombosis","enrollment":136},{"nctId":"NCT04530578","phase":"PHASE4","title":"Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19","status":"UNKNOWN","sponsor":"Clinica San Camilo, Argentina","startDate":"2020-06-01","conditions":"Covid19, Pneumonia","enrollment":200},{"nctId":"NCT04520620","phase":"PHASE4","title":"Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-05-02","conditions":"Sars-CoV2","enrollment":""},{"nctId":"NCT03701750","phase":"PHASE4","title":"Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ET","status":"UNKNOWN","sponsor":"Shenzhen Zhongshan Urology Hospital","startDate":"2018-11-01","conditions":"Infertility","enrollment":240},{"nctId":"NCT04402762","phase":"PHASE1, PHASE2","title":"Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-12-20","conditions":"Enoxaparin","enrollment":20},{"nctId":"NCT04235569","phase":"PHASE4","title":"Warfarin Initiation in Mechanical Mitral Valve Replacement Patients","status":"COMPLETED","sponsor":"Sarah Sabry Hashem","startDate":"2018-03-01","conditions":"Mitral Valve Disease","enrollment":50},{"nctId":"NCT03081169","phase":"PHASE4","title":"Timing of VTE Prophylaxis in TBI","status":"WITHDRAWN","sponsor":"Loyola University","startDate":"2017-04-03","conditions":"TBI (Traumatic Brain Injury), VTE (Venous Thromboembolism)","enrollment":""},{"nctId":"NCT02744833","phase":"PHASE1, PHASE2","title":"Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)","status":"TERMINATED","sponsor":"GlycoMimetics Incorporated","startDate":"2016-07","conditions":"Deep Venous Thrombosis","enrollment":2},{"nctId":"NCT00894283","phase":"EARLY_PHASE1","title":"Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-06","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":198},{"nctId":"NCT01181102","phase":"PHASE3","title":"A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2009-03","conditions":"Venous Thromboembolism","enrollment":716},{"nctId":"NCT01181141","phase":"PHASE3","title":"Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2008-10","conditions":"Venous Thromboembolism","enrollment":92},{"nctId":"NCT01181167","phase":"PHASE3","title":"A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2009-05","conditions":"Prevention, Venous Thromboembolism","enrollment":610},{"nctId":"NCT01203098","phase":"PHASE2","title":"A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2008-07","conditions":"Venous Thromboembolism, Thromboembolism, Thrombosis","enrollment":264},{"nctId":"NCT03841396","phase":"PHASE4","title":"A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.","status":"COMPLETED","sponsor":"Aspen Global Incorporated","startDate":"2016-06-02","conditions":"Injection Site Reaction","enrollment":15},{"nctId":"NCT01696760","phase":"NA","title":"Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2010-10","conditions":"Bone Metastases, Musculoskeletal Cancer, Soft Tissue Sarcoma","enrollment":12},{"nctId":"NCT02271113","phase":"PHASE1","title":"Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"GlycoMimetics Incorporated","startDate":"2014-10","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT03363477","phase":"PHASE1","title":"Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers","status":"COMPLETED","sponsor":"Rovi Pharmaceuticals Laboratories","startDate":"2015-09-25","conditions":"Healthy","enrollment":46},{"nctId":"NCT03254511","phase":"PHASE2","title":"Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer","status":"UNKNOWN","sponsor":"Mashhad University of Medical Sciences","startDate":"2016-07-22","conditions":"Esophageal Neoplasms","enrollment":100},{"nctId":"NCT01308528","phase":"PHASE3","title":"Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery","status":"COMPLETED","sponsor":"Cristália Produtos Químicos Farmacêuticos Ltda.","startDate":"2015-02","conditions":"Venous Thromboembolism","enrollment":243},{"nctId":"NCT00256100","phase":"NA","title":"Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.","status":"TERMINATED","sponsor":"Melbourne Health","startDate":"2004-06","conditions":"Renal Failure","enrollment":20},{"nctId":"NCT02368314","phase":"PHASE3","title":"A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries","status":"COMPLETED","sponsor":"Biocad","startDate":"2015-01","conditions":"Deep Vein Thrombosis","enrollment":124},{"nctId":"NCT00139815","phase":"PHASE3","title":"Michelangelo - Oasis 5","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-04","conditions":"Thromboembolism","enrollment":20078},{"nctId":"NCT02861105","phase":"PHASE4","title":"The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-01","conditions":"Unexplained Infertility","enrollment":716},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT00345618","phase":"PHASE3","title":"Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-06","conditions":"Embolism, Thrombosis","enrollment":3202},{"nctId":"NCT02325479","phase":"PHASE1","title":"Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)","status":"COMPLETED","sponsor":"The Egyptian IVF-ET Center","startDate":"2015-01","conditions":"Infertility","enrollment":120},{"nctId":"NCT01880216","phase":"PHASE3","title":"Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT","status":"COMPLETED","sponsor":"Berlin-Chemie AG Menarini Group","startDate":"2013-06","conditions":"Deep Vein Thrombosis","enrollment":312},{"nctId":"NCT01356992","phase":"PHASE3","title":"Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation","status":"TERMINATED","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2012-07","conditions":"Non ST Segment Elevation Myocardial Infarction, Unstable Angina","enrollment":62},{"nctId":"NCT01064362","phase":"","title":"Hemorrhage Risk Prescribed Arixtra","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-01","conditions":"Thrombosis, Venous","enrollment":13442},{"nctId":"NCT02181985","phase":"PHASE3","title":"Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-05","conditions":"Myocardial Infarction","enrollment":5989},{"nctId":"NCT02159287","phase":"PHASE2","title":"Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke","status":"UNKNOWN","sponsor":"Shiraz University of Medical Sciences","startDate":"2014-01","conditions":"Embolic Stroke","enrollment":80},{"nctId":"NCT00531843","phase":"PHASE2, PHASE3","title":"The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients","status":"COMPLETED","sponsor":"Mary Knudson, M.D.","startDate":"2007-12","conditions":"Venous Thromboembolism","enrollment":105},{"nctId":"NCT00679588","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-04","conditions":"Venous Thromboembolism","enrollment":4413},{"nctId":"NCT00232271","phase":"PHASE4","title":"The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.","status":"TERMINATED","sponsor":"Melbourne Health","startDate":"2005-08","conditions":"Deep Vein Thrombosis","enrollment":35},{"nctId":"NCT00916669","phase":"PHASE2","title":"A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2008-07","conditions":"Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT00721760","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":1003},{"nctId":"NCT00697099","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-06","conditions":"Venous Thromboembolism","enrollment":2326},{"nctId":"NCT00718224","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":1150},{"nctId":"NCT00714597","phase":"PHASE3","title":"Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility","status":"TERMINATED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":421},{"nctId":"NCT00331838","phase":"PHASE2","title":"Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-05","conditions":"Venous Thromboembolism","enrollment":705},{"nctId":"NCT01086046","phase":"NA","title":"Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure","status":"UNKNOWN","sponsor":"Third Military Medical University","startDate":"2009-01","conditions":"Thrombosis","enrollment":450},{"nctId":"NCT01356615","phase":"NA","title":"Low Molecular Weight Heparin for Hemodialysis Anticoagulation","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2011-03","conditions":"End Stage Renal Failure on Dialysis","enrollment":27},{"nctId":"NCT00077844","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-01","conditions":"Percutaneous Coronary Intervention","enrollment":3532},{"nctId":"NCT00077805","phase":"PHASE4","title":"PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2003-08","conditions":"Acute Ischemic Stroke","enrollment":""},{"nctId":"NCT00077753","phase":"PHASE4","title":"EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization","status":"COMPLETED","sponsor":"Sanofi","startDate":"2002-02","conditions":"Venous Thromboembolism","enrollment":4726},{"nctId":"NCT00723216","phase":"PHASE3","title":"Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-03","conditions":"Abdominal Neoplasms","enrollment":151},{"nctId":"NCT00077818","phase":"PHASE4","title":"Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2002-06","conditions":"Acute Coronary Syndrome","enrollment":""},{"nctId":"NCT00685958","phase":"PHASE3","title":"Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-07","conditions":"Hip Fractures","enrollment":54},{"nctId":"NCT00191724","phase":"PHASE2","title":"Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2004-09","conditions":"Submassive Pulmonary Embolism","enrollment":47},{"nctId":"NCT00077792","phase":"PHASE3","title":"Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2002-10","conditions":"Myocardial Infarction, Acute ST-Segment Elevation","enrollment":20506},{"nctId":"NCT00349180","phase":"PHASE3","title":"Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-06","conditions":"Arthroplasty, Replacement, Hip","enrollment":156},{"nctId":"NCT00750451","phase":"NA","title":"Low Molecular Weight Heparin in Recurrent Implantation Failure","status":"COMPLETED","sponsor":"V.K.V. American Hospital, Istanbul","startDate":"2006-01","conditions":"Infertility, Fertilization in Vitro, Recurrent Implantation Failure","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CONFUSIONAL STATE"},{"count":1,"reaction":"CYTOLYTIC HEPATITIS"},{"count":1,"reaction":"GAIT DISTURBANCE"},{"count":1,"reaction":"HYPOKALAEMIA"},{"count":1,"reaction":"NEURALGIA"},{"count":1,"reaction":"PNEUMONIA ASPIRATION"},{"count":1,"reaction":"URINE POTASSIUM DECREASED"}],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Clexane (Sodium Enoxaparine)","BCD-080 (Sodium Enoxaparine)","Clexane placebo","low molecular weight heparin","clexane"],"phase":"marketed","status":"active","brandName":"Sodium Enoxaparine","genericName":"Sodium Enoxaparine","companyName":"Biocad","companyId":"biocad","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium enoxaparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against factors Xa and IIa. Used for Prophylaxis of venous thromboembolism in surgical patients, Treatment of acute deep vein thrombosis, Treatment of acute pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}